Sign in or create an account to add this stock to your watchlist.
About Arcadia Biosciences (NASDAQ:RKDA)
Arcadia Biosciences, Inc., an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits. It also provides nutritional oils comprising gamma linolenic acid safflower oil to manufacturers of dietary and nutritional supplements, medical foods, dog food, and other products under the SONOVA brand; and arachidonic acid safflower oil that is used as an ingredient in infant nutrition products. In addition, the company has various programs under development comprising fiber resistant starch wheat, whole grain flour, and reduced gluten wheat programs. Arcadia Biosciences, Inc. has strategic collaboration with Dow AgroSciences to develop and commercialize enhanced wheat quality trait. The company was founded in 2002 and is headquartered in Davis, California.
Industry, Sector and Symbol
Industry Agricultural chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNASDAQ:RKDA
CUSIPN/A
Phone530-756-7077
Debt
Debt-to-Equity RatioN/A
Current Ratio7.01
Quick Ratio6.91
Price-To-Earnings
Trailing P/E Ratio-1.50
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$4.03 million
Price / Sales6.32
Cash FlowN/A
Price / CashN/A
Book Value$3.75 per share
Price / Book2.74
Profitability
EPS (Most Recent Fiscal Year)($6.86)
Net Income$-15,700,000.00
Net Margins-686.10%
Return on Equity-259.46%
Return on Assets-82.98%
Miscellaneous
Employees42
Outstanding Shares2,480,000
Arcadia Biosciences (NASDAQ:RKDA) Frequently Asked Questions
What is Arcadia Biosciences' stock symbol?
Arcadia Biosciences trades on the NASDAQ under the ticker symbol "RKDA."
When did Arcadia Biosciences' stock split? How did Arcadia Biosciences' stock split work?
Shares of Arcadia Biosciences reverse split on Wednesday, January 24th 2018. The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 23rd 2018. An investor that had 100 shares of Arcadia Biosciences stock prior to the reverse split would have 5 shares after the split.
How were Arcadia Biosciences' earnings last quarter?
Arcadia Biosciences (NASDAQ:RKDA) released its earnings results on Wednesday, May, 9th. The basic materials company reported ($4.86) EPS for the quarter. The basic materials company had revenue of $0.21 million for the quarter. Arcadia Biosciences had a negative return on equity of 259.46% and a negative net margin of 686.10%. View Arcadia Biosciences' Earnings History.
When is Arcadia Biosciences' next earnings date?
What price target have analysts set for RKDA?
1 brokerages have issued 1-year price targets for Arcadia Biosciences' stock. Their forecasts range from $20.00 to $20.00. On average, they anticipate Arcadia Biosciences' stock price to reach $20.00 in the next twelve months. View Analyst Ratings for Arcadia Biosciences.
Who are some of Arcadia Biosciences' key competitors?
Who are Arcadia Biosciences' key executives?
Arcadia Biosciences' management team includes the folowing people:
- Mr. Rajendra Ketkar, Pres, CEO & Director (Age 64)
- Mr. Matthew T. Plavan, CFO & Sec. (Age 54)
- Dr. Zhongjin Lu Ph.D., VP of Product Devel. (Age 52)
- Ms. Sarah Reiter, Chief Commercial Officer (Age 46)
When did Arcadia Biosciences IPO?
(RKDA) raised $66 million in an initial public offering on Friday, May 15th 2015. The company issued 8,200,000 shares at a price of $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray acted as the underwriters for the IPO.
Has Arcadia Biosciences been receiving favorable news coverage?
News coverage about RKDA stock has been trending somewhat positive on Tuesday, Accern Sentiment reports. The research firm ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Arcadia Biosciences earned a media sentiment score of 0.02 on Accern's scale. They also assigned media coverage about the basic materials company an impact score of 46.52 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
Who are Arcadia Biosciences' major shareholders?
Arcadia Biosciences' stock is owned by a number of of retail and institutional investors. Top institutional investors include
MORAL COMPASS CORP
(52.80%) and Sabby Management LLC (6.06%). Company insiders that own Arcadia Biosciences stock include Eric J Rey, Roger Salameh, Steven F Brandwein and Zhongjin Lu. View Institutional Ownership Trends for Arcadia Biosciences.
Which major investors are buying Arcadia Biosciences stock?
How do I buy shares of Arcadia Biosciences?
Shares of RKDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Arcadia Biosciences' stock price today?
One share of RKDA stock can currently be purchased for approximately $10.27.
How big of a company is Arcadia Biosciences?
Arcadia Biosciences has a market capitalization of $24.32 million and generates $4.03 million in revenue each year. The basic materials company earns $-15,700,000.00 in net income (profit) each year or ($6.86) on an earnings per share basis. Arcadia Biosciences employs 42 workers across the globe.
How can I contact Arcadia Biosciences?
Arcadia Biosciences' mailing address is 202 COUSTEAU PLACE SUITE 105, DAVIS CA, 85018. The basic materials company can be reached via phone at 530-756-7077 or via email at [email protected]
MarketBeat Community Rating for Arcadia Biosciences (RKDA)
MarketBeat's community ratings are surveys of what our community members think about Arcadia Biosciences and other stocks. Vote "Outperform" if you believe RKDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RKDA will underperform the S&P 500 over the long term. You may vote once every thirty days.
Arcadia Biosciences (NASDAQ:RKDA) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Arcadia Biosciences in the last 12 months. Their average twelve-month price target is $20.00, suggesting that the stock has a possible upside of 94.74%. The high price target for RKDA is $20.00 and the low price target for RKDA is $20.00. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.00 | 2.00 | 2.00 | 2.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $20.00 | $20.00 | $20.00 | $20.00 |
| Price Target Upside: | 94.74% upside | 58.32% downside | 96.08% upside | 96.08% upside |
Arcadia Biosciences (NASDAQ:RKDA) Consensus Price Target History
Arcadia Biosciences (NASDAQ:RKDA) Analyst Ratings History
Show:
(Data available from 5/22/2016 forward)
Arcadia Biosciences (NASDAQ:RKDA) Earnings History and Estimates Chart
Arcadia Biosciences (NASDAQ RKDA) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/8/2018 | | | | | | | N/A |  |
| 5/9/2018 | Q1 2018 | | ($4.86) | | $0.21 million | View | N/A | |
| 3/20/2018 | Q4 2017 | ($2.00) | ($1.39) | | $1.43 million | View | N/A | |
| 11/9/2017 | Q3 2017 | ($1.60) | ($2.20) | | $0.59 million | View | N/A | |
| 8/10/2017 | Q2 2017 | ($2.20) | ($1.88) | | $0.99 million | View | N/A | |
| 5/10/2017 | Q1 2017 | ($1.40) | ($2.00) | | $1.02 million | View | N/A | |
| 3/8/2017 | Q4 2016 | ($2.00) | ($2.56) | | $0.54 million | View | Listen | |
| 11/10/2016 | Q316 | ($1.40) | ($1.80) | $2.10 million | $1.08 million | View | Listen | |
| 8/9/2016 | Q216 | ($1.40) | ($2.00) | $1.90 million | $0.72 million | View | Listen | |
| 5/10/2016 | Q116 | ($1.40) | ($2.40) | $1.60 million | $0.85 million | View | Listen | |
| 3/8/2016 | Q415 | ($1.40) | ($1.80) | $2.40 million | $1.35 million | View | Listen | |
| 11/5/2015 | Q315 | ($1.40) | ($2.20) | $2.40 million | $1.82 million | View | N/A | |
| 8/10/2015 | Q215 | ($2.20) | ($3.80) | $2.90 million | $1.43 million | View | Listen | |
(Earnings results data provided by Zacks Investment Research)
Arcadia Biosciences (NASDAQ:RKDA) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Arcadia Biosciences (NASDAQ RKDA) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 17.70%
Institutional Ownership Percentage: 15.20%
Arcadia Biosciences (NASDAQ RKDA) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/23/2018 | Eric J Rey | Director | Sell | 5,000 | $33.44 | $167,200.00 | 12,335 | |
| 3/23/2018 | Zhongjin Lu | VP | Sell | 1,750 | $32.74 | $57,295.00 | 2,308 | |
| 3/15/2018 | Eric J Rey | Director | Sell | 21,255 | $45.38 | $964,551.90 | 28,340 | |
| 11/17/2017 | Zhongjin Lu | VP | Sell | 5,950 | $0.23 | $1,368.50 | 11,153 | |
| 6/8/2017 | Eric J Rey | Director | Buy | 5,000 | $0.75 | $3,750.00 | 146,680 | |
| 8/4/2016 | Roger Salameh | COO | Sell | 100 | $2.51 | $251.00 | 11,515 | |
| 6/13/2016 | Steven F Brandwein | Insider | Sell | 8,280 | $2.49 | $20,617.20 | 750 | |
| 4/25/2016 | Steven F Brandwein | Insider | Sell | 1,720 | $2.42 | $4,162.40 | 9,030 | |
| 4/5/2016 | Vic C Knauf | Insider | Sell | 2,853 | $2.98 | $8,501.94 | 48,334 | |
| 3/4/2016 | Vic C Knauf | Insider | Sell | 3,273 | $3.20 | $10,473.60 | 47,434 | |
| 2/3/2016 | Eric J. Rey | CEO | Sell | 3,200 | $2.92 | $9,344.00 | 140,180 | |
| 2/1/2016 | Vic C. Knauf | insider | Sell | 1,666 | $3.00 | $4,998.00 | 47,134 | |
| 12/15/2015 | Steven F. Brandwein | insider | Sell | 10,035 | $3.57 | $35,824.95 | 10,000 | |
| 12/2/2015 | Vic C. Knauf | insider | Sell | 15,000 | $4.01 | $60,150.00 | 47,134 | |
| 11/11/2015 | Vic C. Knauf | insider | Sell | 4,527 | $2.91 | $13,173.57 | 47,134 | |
| 10/9/2015 | Eric J. Rey | CEO | Sell | 5,145 | $3.01 | $15,486.45 | 139,630 | |
| 10/8/2015 | Eric J. Rey | CEO | Sell | 9,100 | $3.13 | $28,483.00 | 128,993 | |
| 10/5/2015 | Eric J. Rey | CEO | Sell | 21,636 | $3.07 | $66,422.52 | 110,160 | |
| 9/30/2015 | Eric J. Rey | CEO | Sell | 15,900 | $3.46 | $55,014.00 | 64,160 | |
| 9/25/2015 | Eric J. Rey | CEO | Sell | 21,089 | $4.27 | $90,050.03 | 35,803 | |
| 9/14/2015 | Don Emlay | VP | Sell | 3,521 | $4.95 | $17,428.95 | 17,729 | |
| 9/11/2015 | Zhongjin Lu | VP | Sell | 1,068 | $4.92 | $5,254.56 | 14,760 | |
| 9/10/2015 | Vic C. Knauf | insider | Sell | 6,840 | $5.50 | $37,620.00 | 31,661 | |
| 9/10/2015 | Zhongjin Lu | VP | Sell | 6,672 | $5.48 | $36,562.56 | 12,870 | |
| 5/20/2015 | Terri C Bishop | Major Shareholder | Buy | 1,000,000 | $8.00 | $8,000,000.00 | | |
| 5/20/2015 | Uday Garg | Director | Buy | 375,000 | $8.00 | $3,000,000.00 | | |
(Data available from 1/1/2013 forward)
Arcadia Biosciences (NASDAQ RKDA) News Headlines
| Source: |
|
Arcadia Biosciences (NASDAQ:RKDA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Arcadia Biosciences (NASDAQ:RKDA) Income Statement, Balance Sheet and Cash Flow Statement
Arcadia Biosciences (NASDAQ RKDA) Stock Chart for Tuesday, May, 22, 2018
Loading chart…
